论文部分内容阅读
八十年代以来,由于医药科学工作者的不懈努力,使得抗肿瘤药物的研究步入了一个新的里程。尤其是在生物学反应调节剂和抗肿瘤抗生素方面进展更快。本文就此作一概述。生物学反应调节剂生物学反应调节剂(Biological response modifier,BRM)是近年来提出的新类型药物,它通过调节机体的防御功能提高抗病能力,尤常用于癌瘤的辅助治疗。这类药物有: 一、来源于微生物而结构未确定的药物结核菌苗(卡介苗,BCG,Bacillus Calmette—Guerin)本品是碱毒的牛型结核杆菌活菌苗,原用于结核病预防,现亦用作生物反应调节剂。它与一些抗原同时免疫
Since the 1980s, due to the unremitting efforts of medical scientists, anti-cancer drug research has taken a new milestone. In particular, biological response modifiers and antitumor antibiotics progress faster. This article gives an overview of this. Biological response modifier Biological response modifier (BRM) is a new type of drug proposed in recent years. It enhances disease resistance by regulating the body’s defense function, especially for the adjuvant treatment of cancer. These drugs are: First, the structure from the microbe and the structure of the drug TB TB vaccine (Bacillus Calmette-BCG, Bacillus Calmette-Guerin) This product is alkaline poisoning Mycobacterium bovis bacillus vaccine, used to prevent tuberculosis, is Also used as a biological response modifier. It is immunized with some antigens simultaneously